Drug intelligence / Profile preview

beta-sodium glycerophosphate

Development stage
Unknown
Lead developer
Fresenius Kabi
Modality
Small Molecules
Administration
Intravenous, Local Injection, Topical, Transdermal
01

Overview

beta-sodium glycerophosphate is an organic phosphate salt primarily utilized in regenerative medicine and clinical nutrition. It serves as a source of organic phosphorus and a critical substrate for the enzyme alkaline phosphatase (ALP). In the context of tissue engineering and bone biology, it is a standard supplement used to induce the osteogenic differentiation of mesenchymal stem cells; ALP-mediated hydrolysis of the beta-glycerophosphate molecule releases inorganic phosphate ions, which subsequently facilitate the mineralization of the extracellular matrix into hydroxyapatite. Furthermore, it is widely employed as a temperature-sensitive gelation agent in chitosan-based hydrogels, enabling the creation of injectable scaffolds for cartilage repair and localized drug delivery. In clinical medicine, the sodium glycerophosphate family is used as a parenteral supplement to prevent and treat hypophosphatemia, providing a stable source of phosphate for patients receiving intravenous nutrition.

Other names
sodium beta-glycerophosphatebeta-GPbeta-glycerophosphate disodium saltdisodium glycerol-2-phosphatesodium 2-glycerophosphatesodium2-glycerophosphatesodium-2-glycerophosphatedisodium beta-glycerophosphate
02

Targets

ALPL (Tissue-nonspecific alkaline phosphatase)

Beyond the preview

Go deeper on beta-sodium glycerophosphate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on beta-sodium glycerophosphate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call